Chandel HS - Search Results

1

Interdependencies between Toll-like receptors in Leishmania infection.

Shukla D, Patidar A, Sarma U, Chauhan P, Pandey SP, Chandel HS, Bodhale N, Ghosh SK, Guzman CA, Ebensen T, Silvestre R, Sarkar A, Saha B, Bhattacharjee S. Shukla D, et al. Among authors: chandel hs. Immunology. 2021 Sep;164(1):173-189. doi: 10.1111/imm.13364. Epub 2021 May 26. Immunology. 2021. PMID: 33964011 Free PMC article.

2

Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice.

Vishwakarma V, Pati NB, Chandel HS, Sahoo SS, Saha B, Suar M. Vishwakarma V, et al. Among authors: chandel hs. PLoS One. 2012;7(12):e52043. doi: 10.1371/journal.pone.0052043. Epub 2012 Dec 17. PLoS One. 2012. PMID: 23284865 Free PMC article.

3

Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.

Srivastava S, Pandey SP, Jha MK, Chandel HS, Saha B. Srivastava S, et al. Among authors: chandel hs. Clin Exp Immunol. 2013 Jun;172(3):403-9. doi: 10.1111/cei.12074. Clin Exp Immunol. 2013. PMID: 23600828 Free PMC article.

4

Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection.

Chandel HS, Pandey SP, Shukla D, Lalsare K, Selvaraj SK, Jha MK, Saha B. Chandel HS, et al. Clin Exp Immunol. 2014 May;176(2):283-90. doi: 10.1111/cei.12264. Clin Exp Immunol. 2014. PMID: 24387292 Free PMC article.

5

TLR-CD40 Cross-Talk in Anti-Leishmanial Immune Response.

Chandel HS, Pandey SP, Roy S, Doyen N, Saha B. Chandel HS, et al. Front Immunol. 2014 May 16;5:220. doi: 10.3389/fimmu.2014.00220. eCollection 2014. Front Immunol. 2014. PMID: 24904575 Free PMC article. Review. No abstract available.

6

Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.

Pandey SP, Chandel HS, Srivastava S, Selvaraj S, Jha MK, Shukla D, Ebensen T, Guzman CA, Saha B. Pandey SP, et al. Among authors: chandel hs. J Immunol. 2014 Oct 1;193(7):3632-43. doi: 10.4049/jimmunol.1400672. Epub 2014 Sep 5. J Immunol. 2014. PMID: 25194056

7

TLR9-deficiency reduces TLR1, TLR2 and TLR3 expressions in Leishmania major-infected macrophages.

Pandey SP, Doyen N, Mishra GC, Saha B, Chandel HS. Pandey SP, et al. Among authors: chandel hs. Exp Parasitol. 2015 Jul;154:82-6. doi: 10.1016/j.exppara.2015.04.005. Epub 2015 Apr 21. Exp Parasitol. 2015. PMID: 25911242

8

Counteractive functions are encrypted in the residues of CD154.

Bandyopadhyay S, Chandel HS, Singh S, Roy S, Krishnasastry MV, Saha B. Bandyopadhyay S, et al. Among authors: chandel hs. Hum Immunol. 2015 Sep;76(9):673-80. doi: 10.1016/j.humimm.2015.09.019. Epub 2015 Sep 30. Hum Immunol. 2015. PMID: 26429321

9

TLR11 or TLR12 silencing reduces Leishmania major infection.

Shukla D, Chandel HS, Srivastava S, Chauhan P, Pandey SP, Patidar A, Banerjee R, Chattopadhyay D, Saha B. Shukla D, et al. Among authors: chandel hs. Cytokine. 2018 Apr;104:110-113. doi: 10.1016/j.cyto.2017.10.005. Epub 2017 Oct 7. Cytokine. 2018. PMID: 29017773

10

Myotubularin-related protein-6 silencing protects mice from Leishmania donovani infection.

Jha MK, Chandel HS, Pandey SP, Sarode A, Bodhale N, Bhattacharya-Majumdar S, Majumdar S, Saha B. Jha MK, et al. Among authors: chandel hs. Int Immunopharmacol. 2024 Mar 10;129:111589. doi: 10.1016/j.intimp.2024.111589. Epub 2024 Jan 30. Int Immunopharmacol. 2024. PMID: 38295542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page